2025 annual financial data
Harvard Bioscience 2025 Operating margin
Harvard Bioscience 2025 operating margin with verified reported values.
Direct answer
Operating margin was -0.73%.
Operating income was -629,000 USD and net income was -56,700,000 USD.
Operating cash flow was 6,729,000 USD.
Get free Harvard Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 86,550,000 USD
- Operating income
- -629,000 USD
- Net income
- -56,700,000 USD
- Operating cash flow
- 6,729,000 USD